Izzo A A, Mascolo N, Di Urno M V, Autore G, Di Carlo G, Capasso F
Department of Experimental Pharmacology, University of Naples Federico II, Italy.
Agents Actions. 1994 May;41(3-4):140-3. doi: 10.1007/BF02001907.
Carrageenin oedema is enhanced by the simultaneous injection in the rat paw of platelet activating factor (PAF). The enhancement of carrageenin oedema is observed throughout the time course of the experiments. This enhancement is also present when the oedema-producing agent is dextran, cellulose sulphate, histamine, 5-hydroxytryptamine, bradykinin or prostaglandin E2. Both verapamil and BN 52021 abolished the enhancement induced by PAF without modifying significantly carrageenin oedema. In essential fatty acid deficient (EFAD) rats depleted of kininogen and amines, carrageenin oedema is not modified by PAF. These findings suggest that PAF interacts with other inflammatory mediators regulating the formation of oedema induced by irritants injected locally.
在大鼠爪中同时注射血小板活化因子(PAF)可增强角叉菜胶性水肿。在整个实验过程中均观察到角叉菜胶性水肿增强。当致水肿剂为右旋糖酐、硫酸纤维素、组胺、5-羟色胺、缓激肽或前列腺素E2时,这种增强作用也存在。维拉帕米和BN 52021均可消除PAF诱导的增强作用,而对角叉菜胶性水肿无明显影响。在缺乏激肽原和胺类的必需脂肪酸缺乏(EFAD)大鼠中,PAF对角叉菜胶性水肿无影响。这些发现提示PAF与其他炎症介质相互作用,调节局部注射刺激物诱导的水肿形成。